Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-110979
Filing Date
2025-11-14
Accepted
2025-11-14 16:50:40
Documents
66
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0262047-10q_actinium.htm   iXBRL 10-Q 946811
2 CERTIFICATION ea026204701ex31-1_actinium.htm EX-31.1 10006
3 CERTIFICATION ea026204701ex31-2_actinium.htm EX-31.2 9863
4 CERTIFICATION ea026204701ex32-1_actinium.htm EX-32.1 3922
5 CERTIFICATION ea026204701ex32-2_actinium.htm EX-32.2 3875
6 LETTER FROM NOVARTIS PHARMACEUTICALS CORPORATION, DATED AUGUST 5, 2025 ea026204701ex99-1_actinium.htm EX-99.1 32562
7 GRAPHIC image_001.jpg GRAPHIC 34031
8 GRAPHIC image_002.jpg GRAPHIC 102133
9 GRAPHIC image_003.jpg GRAPHIC 29571
10 GRAPHIC image_004.jpg GRAPHIC 14394
11 GRAPHIC image_005.jpg GRAPHIC 12234
12 GRAPHIC image_006.jpg GRAPHIC 18081
13 GRAPHIC image_007.jpg GRAPHIC 15905
14 GRAPHIC image_008.jpg GRAPHIC 14501
15 GRAPHIC image_009.jpg GRAPHIC 14657
16 GRAPHIC image_010.jpg GRAPHIC 12931
17 GRAPHIC image_011.jpg GRAPHIC 21373
18 GRAPHIC image_012.jpg GRAPHIC 10974
19 GRAPHIC image_013.jpg GRAPHIC 16762
20 GRAPHIC image_014.jpg GRAPHIC 11424
21 GRAPHIC image_015.jpg GRAPHIC 10442
22 GRAPHIC image_016.jpg GRAPHIC 11389
23 GRAPHIC image_017.jpg GRAPHIC 10043
24 GRAPHIC ex99-1_001.jpg GRAPHIC 7815
  Complete submission text file 0001213900-25-110979.txt   4880589

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE atnm-20250930.xsd EX-101.SCH 26106
26 XBRL CALCULATION FILE atnm-20250930_cal.xml EX-101.CAL 25604
27 XBRL DEFINITION FILE atnm-20250930_def.xml EX-101.DEF 139283
28 XBRL LABEL FILE atnm-20250930_lab.xml EX-101.LAB 303148
29 XBRL PRESENTATION FILE atnm-20250930_pre.xml EX-101.PRE 156665
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0262047-10q_actinium_htm.xml XML 329624
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 251487725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)